| Pathophysiology, diagnosis, and management of dyslipidemia. | |
| | |
MedLine Citation:
|
PMID: 16824902 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Atherosclerosis is a systemic diffuse disease that may manifest as an anglographically localized coronary, cerebral, mesenteric, renal, and/or peripheral arterial stenosis or as diffuse atherosclerosis. While relief of organ ischemia is frequently possible with percutaneous or surgical revascularization, this in itself does not alleviate the long-term risks of disease recurrence or modify the metabolic derangements that promote atherosclerosis. It is critically important to recognize the need for treatment of dyslipidemia and to institute necessary therapies. The complex role of lipoprotein abnormalities is well understood and the use of lipid-lowering agents (90% statins) is reviewed in both primary and secondary prevention. The clinical interaction with novel risk factors and the practical problems in patient management are discussed. |
| | |
Authors:
|
Gerald T Gau; R Scott Wright |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review |
Journal Detail:
|
Title: Current problems in cardiology Volume: 31 ISSN: 0146-2806 ISO Abbreviation: Curr Probl Cardiol Publication Date: 2006 Jul |
Date Detail:
|
Created Date: 2006-07-07 Completed Date: 2006-08-29 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7701802 Medline TA: Curr Probl Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 445-86 Citation Subset: IM |
Affiliation:
|
Mayo College of Medicine, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antilipemic Agents
/
therapeutic use* Atherosclerosis / diagnosis, etiology, prevention & control Biological Markers / blood Cholesterol / blood* Diagnosis, Differential Disease Progression Dyslipidemias* / diagnosis, drug therapy, physiopathology Humans Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antilipemic Agents; 0/Biological Markers; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Circulating endothelial progenitor cells predict coronary artery disease severity.
Next Document: Meiotic diapause: how a sperm signal sets you free.